Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (452)	12/27/1997 12:58:00 PM
From: Brander	Read Replies (1) \| Respond to of 834

Opinions are valid. Making statements such as there is a 100% chance that the FDA will not approve their drug is not valid. You stated that as a fact, not an opinion, and you have not presented on shred of evidence to support that statement. I think the FDA understands clinical trials, the scientific method, and statistics much better than you. The FDA would have never granted rapid review if the results were statisticaly insigificant. I have no problem listening to your opinions, if they are stated as such. I do have a problem listening to your reckless slanderous statements, and that is exactly what they are, by definition, until you provide some evidence for what you have to say. Brad